Last updated: May 27, 2026
LOPURIN drug suppliers: Who manufactures and supplies the product across markets?
Who supplies LOPURIN (lopurin) to pharmacies and wholesalers?
LOPURIN is supplied through a standard chain that typically splits into (1) manufacturers that produce the finished dosage form and (2) branded/distributor networks that move inventory to wholesale and retail channels. However, there is insufficient data in the provided prompt to identify the actual manufacturer(s), marketing authorization holder(s), or distributor names tied specifically to the brand “LOPURIN” for each jurisdiction.
What manufacturing companies make LOPURIN (active ingredient and dosage form)?
No verified details are provided for:
- active ingredient (and salt/strength),
- dosage form (tablet, capsule, syrup, injection, etc.),
- strength(s),
- authorization holder or branded labeler name,
- country-level product registrations.
Without those inputs, manufacturer attribution cannot be produced accurately.
Which distributors sell LOPURIN in the US (FDA/labeler network)?
No US labeling/NDC information, FDA labeler, or Orange Book entry is included. Without an NDC labeler or FDA listing, distributor and manufacturer identification cannot be completed.
What are the key suppliers of LOPURIN in Europe (national authorization holders)?
No EMA national authorization, marketing authorization holder, or product registration data is supplied. Lacking jurisdictional registration identifiers, manufacturer and supplier mapping across EU countries cannot be done.
How many suppliers exist for LOPURIN worldwide, and are there multiple MAHs?
No product scope is given (originator vs. generic, or which market’s brand name “LOPURIN” refers to). “LOPURIN” can be used for different formulations in different countries, which changes the supplier set.
What suppliers exist for LOPURIN API (active pharmaceutical ingredient) and intermediates?
No API name, CAS number, or API supplier list is provided. API supplier identification requires at minimum the exact API identity and market-specific procurement documentation (DMF, CEP, or supply chain disclosures), none of which are included.
How do regulatory filings identify LOPURIN suppliers (DMF/CEP/MA dossier)?
No DMF/CEP numbers, reference listed drug, or authorization dossier identifiers are provided. Supplier identification via regulatory filings cannot be generated from the prompt alone.
Does LOPURIN have biosimilar or generic supplier overlap that changes sourcing?
No reference drug status, reference listed drug link, or generic entry information is provided. For non-biologics, supplier overlap depends on formulation and labeling specifics; for biologics, it requires biosimilar comparability mapping, neither present.
Key Takeaways
No verifiable supplier roster can be produced from the information provided. Accurate manufacturer and distributor mapping for “LOPURIN” requires product-identifying details that are not included in the prompt.
FAQs
- Which company is the NDC labeler for LOPURIN in the US?
- What is the marketing authorization holder for LOPURIN in the UK or EU?
- Who supplies the LOPURIN API under DMF or CEP?
- Are there multiple strengths or dosage forms of LOPURIN that have different manufacturers?
- Does LOPURIN face any supply interruptions due to manufacturing site constraints?
References
(No sources were provided or cited in the prompt.)
